CN1434808A - 新的3-氨基-1-苯基-1h-[1,2,4]三唑的支链取代氨基衍生物、其制备方法和含有它们的药物 - Google Patents
新的3-氨基-1-苯基-1h-[1,2,4]三唑的支链取代氨基衍生物、其制备方法和含有它们的药物 Download PDFInfo
- Publication number
- CN1434808A CN1434808A CN00819078A CN00819078A CN1434808A CN 1434808 A CN1434808 A CN 1434808A CN 00819078 A CN00819078 A CN 00819078A CN 00819078 A CN00819078 A CN 00819078A CN 1434808 A CN1434808 A CN 1434808A
- Authority
- CN
- China
- Prior art keywords
- cyclopropyl
- alkyl
- triazole
- ethyl
- propyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR99/15935 | 1999-12-17 | ||
FR9915935A FR2802530B1 (fr) | 1999-12-17 | 1999-12-17 | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1434808A true CN1434808A (zh) | 2003-08-06 |
CN1293061C CN1293061C (zh) | 2007-01-03 |
Family
ID=9553380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB00819078XA Expired - Fee Related CN1293061C (zh) | 1999-12-17 | 2000-12-14 | 新的3-氨基-1-苯基-1h-[1,2,4]三唑的支链取代氨基衍生物、其制备方法和含有它们的药物组合物 |
Country Status (34)
Country | Link |
---|---|
US (1) | US6806282B2 (zh) |
EP (1) | EP1242389B1 (zh) |
JP (1) | JP4146641B2 (zh) |
KR (1) | KR100705525B1 (zh) |
CN (1) | CN1293061C (zh) |
AR (1) | AR031837A1 (zh) |
AT (1) | ATE264847T1 (zh) |
AU (1) | AU780711B2 (zh) |
BR (1) | BR0017023A (zh) |
CA (1) | CA2398772C (zh) |
CO (1) | CO5251379A1 (zh) |
CZ (1) | CZ302460B6 (zh) |
DE (1) | DE60010126T2 (zh) |
DK (1) | DK1242389T3 (zh) |
EA (1) | EA004957B1 (zh) |
EE (1) | EE04778B1 (zh) |
ES (1) | ES2219436T3 (zh) |
FR (1) | FR2802530B1 (zh) |
HK (1) | HK1055947A1 (zh) |
HU (1) | HUP0204080A3 (zh) |
IL (2) | IL150037A0 (zh) |
IS (1) | IS2315B (zh) |
ME (1) | MEP12108A (zh) |
MX (1) | MXPA02006033A (zh) |
NO (1) | NO20022828L (zh) |
PL (1) | PL203819B1 (zh) |
PT (1) | PT1242389E (zh) |
RS (1) | RS50289B (zh) |
SK (1) | SK285994B6 (zh) |
TR (2) | TR200201600T2 (zh) |
TW (1) | TWI289554B (zh) |
UA (1) | UA73333C2 (zh) |
WO (1) | WO2001044207A2 (zh) |
ZA (1) | ZA200204422B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102066343A (zh) * | 2008-03-19 | 2011-05-18 | 詹森药业有限公司 | 作为烟碱乙酰胆碱受体调节剂的三取代1,2,4-三唑类 |
CN104059027A (zh) * | 2014-07-01 | 2014-09-24 | 河北大学 | 一类含1, 2, 4-三唑的(e)-甲氧基亚氨基苯乙酸甲酯类化合物及其制备方法和用途 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4889489B2 (ja) * | 2003-08-06 | 2012-03-07 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼのインヒビターとして有用なアミノトリアゾール化合物 |
JO3019B1 (ar) | 2006-04-19 | 2016-09-05 | Janssen Pharmaceutica Nv | ثلاثي مستبدل 4،2،1-ثلاثي زولات |
JO2784B1 (en) | 2007-10-18 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | 5,3,1 - Triazole substitute derivative |
ES2424023T3 (es) | 2007-10-18 | 2013-09-26 | Janssen Pharmaceutica N.V. | 1,2,4-triazoles trisustituidos |
BRPI0912196A2 (pt) | 2008-05-09 | 2015-10-06 | Janssen Pharmaceutica Nv | pirazóis trissubstituídos como moduladores do receptor de acetilcolina. |
WO2012054366A2 (en) * | 2010-10-21 | 2012-04-26 | Merck Sharp & Dohme Corp. | Substituted amino-triazolyl pde10 inhibitors |
CA3155599A1 (en) | 2014-01-21 | 2015-07-30 | Neurocrine Biosciences, Inc. | Crf1 receptor antagonists for the treatment of congenital adrenal hyperplasia |
EP4041726A1 (en) * | 2019-09-25 | 2022-08-17 | Molecure SA | Process for the production of 5-(4-((2 s,5 s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1 h-1,2,4-triazol-3-amine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3869167D1 (de) * | 1987-03-27 | 1992-04-23 | Kumiai Chemical Industry Co | Phenyltriazol-derivate und insectizid. |
US5795905A (en) * | 1995-06-06 | 1998-08-18 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
FR2763337B1 (fr) * | 1997-05-13 | 1999-08-20 | Sanofi Sa | Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant |
-
1999
- 1999-12-17 FR FR9915935A patent/FR2802530B1/fr not_active Expired - Fee Related
-
2000
- 2000-12-14 TR TR2002/01600T patent/TR200201600T2/xx unknown
- 2000-12-14 HU HU0204080A patent/HUP0204080A3/hu unknown
- 2000-12-14 PT PT00988916T patent/PT1242389E/pt unknown
- 2000-12-14 UA UA2002064623A patent/UA73333C2/uk unknown
- 2000-12-14 SK SK850-2002A patent/SK285994B6/sk not_active IP Right Cessation
- 2000-12-14 DK DK00988916T patent/DK1242389T3/da active
- 2000-12-14 ME MEP-121/08A patent/MEP12108A/xx unknown
- 2000-12-14 TR TR2004/01775T patent/TR200401775T4/xx unknown
- 2000-12-14 KR KR1020027007736A patent/KR100705525B1/ko not_active IP Right Cessation
- 2000-12-14 DE DE60010126T patent/DE60010126T2/de not_active Expired - Lifetime
- 2000-12-14 ES ES00988916T patent/ES2219436T3/es not_active Expired - Lifetime
- 2000-12-14 CZ CZ20022099A patent/CZ302460B6/cs not_active IP Right Cessation
- 2000-12-14 RS YUP-439/02A patent/RS50289B/sr unknown
- 2000-12-14 IL IL15003700A patent/IL150037A0/xx active IP Right Grant
- 2000-12-14 AU AU25259/01A patent/AU780711B2/en not_active Ceased
- 2000-12-14 EP EP00988916A patent/EP1242389B1/fr not_active Expired - Lifetime
- 2000-12-14 MX MXPA02006033A patent/MXPA02006033A/es active IP Right Grant
- 2000-12-14 EA EA200200523A patent/EA004957B1/ru not_active IP Right Cessation
- 2000-12-14 AT AT00988916T patent/ATE264847T1/de active
- 2000-12-14 CN CNB00819078XA patent/CN1293061C/zh not_active Expired - Fee Related
- 2000-12-14 BR BR0017023-2A patent/BR0017023A/pt active Search and Examination
- 2000-12-14 JP JP2001544697A patent/JP4146641B2/ja not_active Expired - Lifetime
- 2000-12-14 US US10/149,499 patent/US6806282B2/en not_active Expired - Lifetime
- 2000-12-14 EE EEP200200331A patent/EE04778B1/xx not_active IP Right Cessation
- 2000-12-14 CA CA2398772A patent/CA2398772C/fr not_active Expired - Fee Related
- 2000-12-14 CO CO00095200A patent/CO5251379A1/es not_active Application Discontinuation
- 2000-12-14 WO PCT/FR2000/003536 patent/WO2001044207A2/fr active IP Right Grant
- 2000-12-14 PL PL355811A patent/PL203819B1/pl not_active IP Right Cessation
- 2000-12-15 AR ARP000106666A patent/AR031837A1/es not_active Application Discontinuation
-
2001
- 2001-01-29 TW TW089126997A patent/TWI289554B/zh not_active IP Right Cessation
-
2002
- 2002-05-04 IL IL150037A patent/IL150037A/en not_active IP Right Cessation
- 2002-05-28 IS IS6402A patent/IS2315B/is unknown
- 2002-06-03 ZA ZA200204422A patent/ZA200204422B/en unknown
- 2002-06-13 NO NO20022828A patent/NO20022828L/no not_active Application Discontinuation
-
2003
- 2003-11-11 HK HK03108164A patent/HK1055947A1/xx not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102066343A (zh) * | 2008-03-19 | 2011-05-18 | 詹森药业有限公司 | 作为烟碱乙酰胆碱受体调节剂的三取代1,2,4-三唑类 |
CN102066343B (zh) * | 2008-03-19 | 2013-12-04 | 詹森药业有限公司 | 作为烟碱乙酰胆碱受体调节剂的三取代1,2,4-三唑类 |
CN104059027A (zh) * | 2014-07-01 | 2014-09-24 | 河北大学 | 一类含1, 2, 4-三唑的(e)-甲氧基亚氨基苯乙酸甲酯类化合物及其制备方法和用途 |
CN104059027B (zh) * | 2014-07-01 | 2015-10-28 | 河北大学 | 一类含1,2,4-三唑的(e)-甲氧基亚氨基苯乙酸甲酯类化合物及其制备方法和用途 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1028758C (zh) | 吡唑并嘧啶酮类抗心绞痛剂的制备方法 | |
CN1072669C (zh) | 苯并咪唑化合物及其用作gabaa受体复合物调节器的用途 | |
CN1151167C (zh) | 嘌呤衍生物 | |
CN1141043A (zh) | 非肽类速激肽受体拮抗剂 | |
CN1036652C (zh) | 碱式季酰胺,其制备方法及其药物组合物 | |
CN1922162A (zh) | 烷基哌嗪-和烷基高哌嗪-羧酸酯衍生物、其制备方法及其作为faah酶抑制剂的用途 | |
JP5452594B2 (ja) | アルキルチアゾールカルバメート誘導体、この調製、およびfaah酵素阻害剤としてのこの使用 | |
CN1859904A (zh) | 用于治疗阿尔茨海默氏病的苄醚和苄氨基β-分泌酶抑制剂 | |
CN1922138A (zh) | 芳氧基烷基氨基甲酸酯类衍生物,它们的制备方法与治疗用途 | |
CN1422269A (zh) | 1h-咪唑并吡啶衍生物 | |
CN1036569A (zh) | 制备可抑制5-脂氧合酶的4-(4-苯基-1-哌嗪基)苯基衍生物的方法 | |
CN1068329A (zh) | 吡唑并嘧啶酮抗心绞痛剂 | |
CN1287487A (zh) | 氨基苯氧基乙酸衍生物和含有它们的药用组合物 | |
CN1444567A (zh) | 咪唑衍生物 | |
EP0673928A1 (fr) | Nouveaux dérivés de la N-(3,4-dichlorophényl-propyl)-pipéridine comme antagonistes sélectifs du récepteur NK3 humain | |
RU2701858C1 (ru) | Замещенные тиазолы или оксазолы в качестве антагонистов Р2Х7 рецепторов | |
CN1630633A (zh) | 用作缓激肽拮抗剂的在其甲基上具有取代基的n-联苯甲基氨基环烷烃羧酰胺衍生物 | |
CN1934083A (zh) | 作为肾素抑制剂用于治疗高血压的5-氨基-4-羟基-7-(1h-吲哚基甲基)-8-甲基壬酰胺衍生物 | |
CN1478081A (zh) | 取代的2-苯胺基苯并咪唑及其作为nhe抑制剂的用途 | |
CN1293061C (zh) | 新的3-氨基-1-苯基-1h-[1,2,4]三唑的支链取代氨基衍生物、其制备方法和含有它们的药物组合物 | |
CN1016246B (zh) | 氨基酚衍生物的制备方法 | |
CN1370154A (zh) | 氨基噻唑衍生物及其作为crf受体配体的用途 | |
CN1323306A (zh) | 萘啶衍生物 | |
CN1309642A (zh) | 具有止喘、抗变态反应、抗炎、免疫调节和神经保护作用的新的1,2,5-三取代1,2-二氢吲唑-3-酮类化合物、其制备方法以及作为药物的应用 | |
CN1187336C (zh) | 咪唑类衍生物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CI01 | Publication of corrected invention patent application |
Correction item: Denomination of Invention Correct: ...... Their pharmaceutical compositions False: ...... Their drugs Number: 32 Page: 236 Volume: 19 |
|
CI02 | Correction of invention patent application |
Correction item: Denomination of Invention Correct: ...... Their pharmaceutical compositions False: ...... Their drugs Number: 32 Page: The title page Volume: 19 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTION NAME; FROM: THEIR DRUG TO: THEIR DRUG COMBINATION |
|
ERR | Gazette correction |
Free format text: CORRECT: INVENTION NAME; FROM: THEIR DRUG TO: THEIR DRUG COMBINATION |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070103 Termination date: 20161214 |